These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Secondary nucleating sequences affect kinetics and thermodynamics of tau aggregation. Moore CL, Huang MH, Robbennolt SA, Voss KR, Combs B, Gamblin TC, Goux WJ. Biochemistry; 2011 Dec 20; 50(50):10876-86. PubMed ID: 22085312 [Abstract] [Full Text] [Related]
3. Analysis of amylin cleavage products provides new insights into the amyloidogenic region of human amylin. Nilsson MR, Raleigh DP. J Mol Biol; 1999 Dec 17; 294(5):1375-85. PubMed ID: 10600392 [Abstract] [Full Text] [Related]
4. Positional effects of phosphorylation on the stability and morphology of tau-related amyloid fibrils. Inoue M, Konno T, Tainaka K, Nakata E, Yoshida HO, Morii T. Biochemistry; 2012 Feb 21; 51(7):1396-406. PubMed ID: 22304362 [Abstract] [Full Text] [Related]
5. Amyloid-forming propensity of the hydrophobic non-natural amino acid on the fibril-forming core peptide of human tau. Hirata A, Sugimoto K, Konno T, Morii T. Bioorg Med Chem Lett; 2007 Jun 01; 17(11):2971-4. PubMed ID: 17416523 [Abstract] [Full Text] [Related]
6. Destabilization of human IAPP amyloid fibrils by proline mutations outside of the putative amyloidogenic domain: is there a critical amyloidogenic domain in human IAPP? Abedini A, Raleigh DP. J Mol Biol; 2006 Jan 13; 355(2):274-81. PubMed ID: 16303136 [Abstract] [Full Text] [Related]
7. In vitro characterization of lactoferrin aggregation and amyloid formation. Nilsson MR, Dobson CM. Biochemistry; 2003 Jan 21; 42(2):375-82. PubMed ID: 12525164 [Abstract] [Full Text] [Related]
9. Conformational preferences of an amyloidogenic peptide: IR spectroscopy of Ac-VQIVYK-NHMe. Vaden TD, Gowers SA, de Boer TS, Steill JD, Oomens J, Snoek LC. J Am Chem Soc; 2008 Nov 05; 130(44):14640-50. PubMed ID: 18844349 [Abstract] [Full Text] [Related]
14. Observation of beta-sheet aggregation in a gas-phase tau-peptide dimer. Vaden TD, Gowers SA, Snoek LC. J Am Chem Soc; 2009 Feb 25; 131(7):2472-4. PubMed ID: 19178142 [Abstract] [Full Text] [Related]
15. Amyloidogenic peptide/single-walled carbon nanotube composites based on tau-protein-related peptides derived from AcPHF6: preparation and dispersive properties. Muñoz E, Sreelatha A, Garriga R, Baughman RH, Goux WJ. J Phys Chem B; 2013 Jun 27; 117(25):7593-604. PubMed ID: 23745842 [Abstract] [Full Text] [Related]
16. Copper binding properties of a tau peptide associated with Alzheimer's disease studied by CD, NMR, and MALDI-TOF MS. Ma Q, Li Y, Du J, Liu H, Kanazawa K, Nemoto T, Nakanishi H, Zhao Y. Peptides; 2006 Apr 27; 27(4):841-9. PubMed ID: 16225961 [Abstract] [Full Text] [Related]
17. Identification of the core structure of lysozyme amyloid fibrils by proteolysis. Frare E, Mossuto MF, Polverino de Laureto P, Dumoulin M, Dobson CM, Fontana A. J Mol Biol; 2006 Aug 18; 361(3):551-61. PubMed ID: 16859705 [Abstract] [Full Text] [Related]
20. Synthesis and conformational properties of phosphopeptides related to the human tau protein. Du JT, Li YM, Ma QF, Qiang W, Zhao YF, Abe H, Kanazawa K, Qin XR, Aoyagi R, Ishizuka Y, Nemoto T, Nakanishi H. Regul Pept; 2005 Aug 15; 130(1-2):48-56. PubMed ID: 15869817 [Abstract] [Full Text] [Related] Page: [Next] [New Search]